Page last updated: 2024-09-05

succinobucol and thromboxanes

succinobucol has been researched along with thromboxanes in 1 studies

Compound Research Comparison

Studies (succinobucol)	Trials (succinobucol)	Recent Studies (post-2010) (succinobucol)	Studies (thromboxanes)	Trials (thromboxanes)	Recent Studies (post-2010) (thromboxanes)
53	5	16	3,202	149	199

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kunsch, C; Malinin, A; Qiu, FH; Scott, R; Serebruany, V; Xu, XC	1

Trials

1 trial(s) available for succinobucol and thromboxanes

Article	Year
Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy. Journal of thrombosis and thrombolysis, 2009, Volume: 27, Issue:4 Topics: Adolescent; Adult; Aged; Biomarkers; Cells, Cultured; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Humans; Lipoproteins; Male; Middle Aged; Probucol; Risk Factors; Thromboxanes; Vascular Diseases; Young Adult	2009

Article

Year

Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy.

Journal of thrombosis and thrombolysis, 2009, Volume: 27, Issue:4

Topics: Adolescent; Adult; Aged; Biomarkers; Cells, Cultured; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Humans; Lipoproteins; Male; Middle Aged; Probucol; Risk Factors; Thromboxanes; Vascular Diseases; Young Adult

2009